Literature DB >> 17268786

[Complex dietary measures and pharmacotherapy for metabolic syndrome].

A F H Pfeiffer1, A Kohl.   

Abstract

Metabolic syndrome is characterized by a group of risk factors (obesity, glucose metabolism disorders, dyslipidemia and hypertension) which appear to be caused by obesity related mechanisms of cellular metabolism and the systemic energy balance. A fibre poor diet rich in fat combined with lack of physical activity are important causative factors. A suitable change in diet combined with regular physical exercise and a moderate weight loss of about 5% leads to a massive reduction in the consequential disease diabetes type 2 by 60% in pre-diabetics and reduces the risk factors for metabolic syndrome. Pharmacological therapies using metformin or acarbose were about half as effective in reducing new cases of diabetes, while thiazolidinedione also led to a 60% reduction in new diabetes cases in pre-diabetics in spite of a weight increase. A sensible and realizable change in lifestyle provides a highly efficient therapy of metabolic syndrome, in addition to effective pharmacological options.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268786     DOI: 10.1007/s00108-006-1795-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  68 in total

1.  A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort.

Authors:  C Heidemann; K Hoffmann; J Spranger; K Klipstein-Grobusch; M Möhlig; A F H Pfeiffer; H Boeing
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

2.  Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study.

Authors:  David E Laaksonen; Jaana Lindström; Timo A Lakka; Johan G Eriksson; Leo Niskanen; Katja Wikström; Sirkka Aunola; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Timo T Valle; Pirjo Ilanne-Parikka; Anne Louheranta; Helena Hämäläinen; Merja Rastas; Virpi Salminen; Zygimantas Cepaitis; Martti Hakumäki; Hannu Kaikkonen; Pirjo Härkönen; Jouko Sundvall; Jaakko Tuomilehto; Matti Uusitupa
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

3.  Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

Authors:  Floris A van de Laar; Peter L Lucassen; Reinier P Akkermans; Eloy H van de Lisdonk; Guy E Rutten; Chris van Weel
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

4.  Impact of cereal fibre on glucose-regulating factors.

Authors:  M O Weickert; M Mohlig; C Koebnick; J J Holst; P Namsolleck; M Ristow; M Osterhoff; H Rochlitz; N Rudovich; J Spranger; A F H Pfeiffer
Journal:  Diabetologia       Date:  2005-09-20       Impact factor: 10.122

5.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 6.  Should obese patients be counselled to follow a low-glycaemic index diet? No.

Authors:  A Raben
Journal:  Obes Rev       Date:  2002-11       Impact factor: 9.213

7.  Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study.

Authors:  Serge Hercberg; Sandrine Bertrais; Sébastien Czernichow; Nathalie Noisette; Pilar Galan; Adèle Jaouen; Jean Tichet; Serge Briancon; Alain Favier; Louise Mennen; Anne-Marie Roussel
Journal:  Lipids       Date:  2005-04       Impact factor: 1.880

8.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

Review 9.  Beta-blockers and diabetes: the bad guys come good.

Authors:  John Malcolm Cruickshank
Journal:  Cardiovasc Drugs Ther       Date:  2002-09       Impact factor: 3.727

10.  Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition.

Authors:  Mary C Gannon; Frank Q Nuttall
Journal:  Nutr Metab (Lond)       Date:  2006-03-23       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.